IOBT · Categories · Form 4

IOBT - SEC Form 4 insider transactions

IO Biotech Inc. (IOBT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for IOBT

• 367d
  SEC Form 4 filed by Director Smith David V

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 367d
  SEC Form 4 filed by Director Hunter Heidi

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 367d
  SEC Form 4 filed by Director Hirth Peter

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 367d
  SEC Form 4 filed by Director Glaub Kathleen Sereda

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 367d
  SEC Form 4 filed by Director Elling Christian E

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 367d
  SEC Form 4 filed by Director Collins Helen Louise

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 430d
  SEC Form 4 filed by Chief Executive Officer Zocca Mai-Britt

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 430d
  SEC Form 4 filed by Chief Financial Officer Sullivan Amy

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 430d
  SEC Form 4 filed by General Counsel Smith Devin Whittemore

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 430d
  SEC Form 4 filed by Chief Accounting Officer Burkavage Brian

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 430d
  SEC Form 4 filed by Chief Medical Officer Ahmad Qasim Iftikhar

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 682d
  Large owner Novo Holdings A/S sold $99,125 worth of shares (75,000 units at $1.32), decreasing direct ownership by 2% to 4,354,449 units (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Smith David V

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Hunter Heidi

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Hirth Peter

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Glaub Kathleen Sereda

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Elling Christian E

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Collins Helen Louise

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 755d
  Novo Holdings A/S sold $802,495 worth of shares (658,809 units at $1.22), decreasing direct ownership by 13% to 4,429,449 units (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 812d
  SEC Form 4 filed by Zocca Mai-Britt

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 812d
  SEC Form 4 filed by Sullivan Amy

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 812d
  SEC Form 4 filed by Smith Devin Whittemore

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 812d
  SEC Form 4 filed by Burkavage Brian

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 812d
  SEC Form 4 filed by Ahmad Qasim Iftikhar

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 846d
  Novo Holdings A/S sold $988,411 worth of shares (658,809 units at $1.50), decreasing direct ownership by 11% to 5,088,258 units (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 934d
  SEC Form 4 filed by Collins Helen Louise

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1028d
  SEC Form 4 filed by Hunter Heidi

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1032d
  SEC Form 4: Elling Christian E was granted 7,901,234 shares

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1032d
  SEC Form 4: Lundbeckfond Invest A/S was granted 7,901,234 shares, increasing direct ownership by 131% to 13,950,686 units

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1032d
  SEC Form 4: Novo Holdings A/S bought $4,999,998 worth of shares (2,469,135 units at $2.02), increasing direct ownership by 76% to 5,707,467 units

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1033d
  SEC Form 4: Vivo Capital Ix, Llc bought $5,999,999 worth of shares (3,157,894 units at $1.90)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1034d
  SEC Form 4: Zocca Mai-Britt was granted 37,037 shares, increasing direct ownership by 10,462% to 37,391 units

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1034d
  SEC Form 4: Sullivan Amy was granted 49,382 shares, increasing direct ownership by 198% to 74,382 units

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1034d
  SEC Form 4: Smith Devin Whittemore was granted 4,938 shares

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1055d
  SEC Form 4 filed by Ahmad Qasim Iftikhar

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1091d
  SEC Form 4 filed by Glaub Kathleen Sereda

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1091d
  SEC Form 4 filed by Smith David V

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1091d
  SEC Form 4 filed by Nielsen Jack

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1091d
  SEC Form 4 filed by Hirth Peter

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1091d
  SEC Form 4 filed by Elling Christian E

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1174d
  SEC Form 4 filed by Al-Hajj Muhammad

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1174d
  SEC Form 4 filed by Zocca Mai-Britt

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1174d
  SEC Form 4 filed by Sullivan Amy

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1174d
  SEC Form 4 filed by Burkavage Brian

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1174d
  SEC Form 4 filed by Ehrnrooth Eva

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1176d
  SEC Form 4 filed by IO Biotech Inc.

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1242d
  SEC Form 4 filed by Smith Devin Whittemore

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1328d
  SEC Form 4 filed by Sullivan Amy

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1467d
  SEC Form 4 filed by Burkavage Brian

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1469d
  SEC Form 4 filed by Hirth Peter

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1469d
  SEC Form 4 filed by Smith David V

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1469d
  SEC Form 4 filed by Glaub Kathleen Sereda

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1469d
  SEC Form 4 filed by Elling Christian E

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1469d
  SEC Form 4 filed by Nielsen Jack

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1558d
  SEC Form 4 filed by Smith David V

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1669d
  SEC Form 4: Zocca Mai-Britt converted options into 26,580 shares

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1669d
  SEC Form 4: Hbm Healthcare Investments (Cayman) Ltd. converted options into 2,365,545 shares and bought $4,550,000 worth of shares (325,000 units at $14.00)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1669d
  SEC Form 4: Lundbeckfond Invest A/S converted options into 3,906,595 shares and bought $29,999,998 worth of shares (2,142,857 units at $14.00)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1669d
  SEC Form 4: Malier Vanessa converted options into 1,064,036 shares and bought $4,550,000 worth of shares (325,000 units at $14.00)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1669d
  SEC Form 4: Vivo Capital Ix, Llc converted options into 2,365,545 shares and bought $9,100,000 worth of shares (650,000 units at $14.00)

  4 - IO Biotech, Inc. (0001865494) (Issuer)

Other IOBT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends